Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 6,496 shares at $40.41 ($263K) on 2022-12-21, disclosed to the SEC on 2022-12-21.
Open-market sale of $263k MRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.41 | 3,248 | $131K | 50.0% |
| 2 | $40.41 | 3,248 | $131K | 50.0% |
| Total | $40.41 avg | 6,496 | $263K | 100% |
| Filing → |
| MRTX | SELL | 2024-01-09 | $246K | — | Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |